# The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery

> **NCT05727618** · NA · SUSPENDED · sponsor: **Qianfoshan Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Cardiac Surgery
- Hypertension, Pulmonary

## Interventions

- **DRUG:** Pituitrin
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT05727618
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-05-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2029-02-01
- **Target enrollment:** 300 (ESTIMATED)
- **Why stopped:** The clinical research protocol failed to obtain approval from the Institutional Review Board (IRB).
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727618, "The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05727618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*